在急性肺损伤治疗中对中性粒细胞进行操纵的纳米粒子介导的"切断和清理"策略
Jiaxin Li1, Yeyi Hu1, Shuang Chen1
1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
ACS nano
|September 12, 2025
概括
这项研究引入了一种新的"切断和清理"策略,使用S-DE/GD纳米颗粒来治疗急性肺损伤 (ALI). 该方法针对多态核核中性粒细胞 (PMNs),以减少炎症并改善治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- 多态核中性粒细胞 (PMNs) 通过不受控制的透和炎症驱动急性肺损伤 (ALI).
- 针对PMN活动对于有效的ALI治疗至关重要.
研究的目的:
- 通过操纵PMN行为来开发ALI的新型治疗策略.
- 设计S-DE/GD纳米颗粒用于向的PMN抑制和清除.
主要方法:
- 构建的S-DE/GD纳米颗粒与脂质体,硫酸酸 (SHA) 和葡萄糖修饰的多克苏鲁比 (GD).
- 利用SHA通过准P-selectin来抑制PMN透.
- 通过葡萄糖输送器-1.0进行内体逃逸和PMN通过葡萄糖输送器-1.0进行选择性吸收的工程GD.
主要成果:
- 在ALI小鼠模型中,S-DE/GD纳米粒子有效抑制PMN透.
- 在治疗ALI方面表现出显著的治疗疗效.
- 该策略成功地减少了PMN驱动的炎症和肺损伤.
结论:
- 这是一个很棒的节目,这是一个很棒的节目.
- 切断和清理工作进行.
- 使用S-DE/GD的策略显示出对ALI治疗的希望.
- 有针对性的PMN操纵为管理炎症性肺病提供了新的途径.
相关概念视频
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:


